Breast投稿须知_审稿周期

期刊简介

《Breast》是由Churchill Livingstone出版社于1992年创办的英文国际期刊（ISSN: 0960-9776，E-ISSN: 1532-3080），该期刊长期致力于妇产科学领域的创新研究，主要研究方向为医学-妇产科学。作为SCIE收录期刊（JCR分区 Q1，中科院 2区），本刊采用OA未开放获取模式（OA占比0.1379...%），以发表妇产科学领域等方向的原创性研究为核心（研究类文章占比92.56%%）。凭借严格的同行评审与高效编辑流程，期刊年载文量精选控制在121篇，确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库，为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Breast审稿周期约为约1月。该刊近年未被列入国际预警名单，年发文量约121篇，录用竞争适中，主题需确保紧密契合医学前沿。投稿策略提示：避开学术会议旺季投稿以缩短周期，语言建议专业润色提升可读性。

医学大类学科
English 出版语言
否是否预警
SCIE 期刊收录
121 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学 2区 3区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊	综述期刊	大类学科	小类学科
否	否	医学 2区	OBSTETRICS & GYNECOLOGY 妇产科学 ONCOLOGY 肿瘤学 2区 3区

JCR分区

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：OBSTETRICS & GYNECOLOGY	SCIE	Q1	7 / 136	95.2%
学科：ONCOLOGY	SCIE	Q1	54 / 322	83.4%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：OBSTETRICS & GYNECOLOGY	SCIE	Q1	11 / 136	92.28%
学科：ONCOLOGY	SCIE	Q1	38 / 322	88.35%

CiteScore

SJR

SNIP

CiteScore 排名

CiteScore：8.7

SJR：1.688

SNIP：1.69

学科类别	分区	排名	百分位
大类：Medicine 小类：Surgery	Q1	15 / 551	97%
大类：Medicine 小类：Oncology	Q1	70 / 404	82%
大类：Medicine 小类：Cancer Research	Q2	65 / 230	71%

期刊发文

Comparison of clinicopathological characteristics and response to neoadjuvant chemotherapy between HER2-low and HER2-zero breast cancer
Author: Zhou, Shuling; Liu, Ting; Kuang, Xiaying; Zhen, Tiantian; Shi, Huijuan; Lin, Ying; Shao, Nan

Journal: BREAST. 2023; Vol. 67, Issue , pp. 1-7. DOI: 10.1016/j.breast.2022.12.006
Serum sodium ions and chloride ions associated with taxane-induced peripheral neuropathy in Chinese patients with early-stage breast cancer: A nation-wide multicenter study
Author: Zhai, Jingtong; Sun, Xiaoying; Zhao, Fang; Pan, Bo; Li, Huihui; Lv, Zheng; Cao, Mengru; Zhao, Jiuda; Mo, Hongnan; Ma, Fei; Xu, Binghe

Journal: BREAST. 2023; Vol. 67, Issue , pp. 36-45. DOI: 10.1016/j.breast.2022.12.034
The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients
Author: Zheng, Si-Yue; Chen, Chu-Ying; Qi, Wei-Xiang; Cai, Gang; Xu, Cheng; Cai, Rong; Qian, Xiao-Fang; Shen, Kun-Wei; Cao, Lu; Chen, Jia-Yi

Journal: BREAST. 2023; Vol. 68, Issue , pp. 142-148. DOI: 10.1016/j.breast.2023.02.001
Cost-effectiveness of sacituzumab govitecan versus chemotherapy in advanced or metastatic triple-negative breast cancer
Author: Lang, Yitian; Chai, Qingqing; Tao, Wenqi; Liao, Yahui; Liu, Xiaoyan; Wu, Bin

Journal: BREAST. 2023; Vol. 68, Issue , pp. 173-180. DOI: 10.1016/j.breast.2023.02.003
Effects of adjuvant chemotherapy in T1N0M0 triple-negative breast cancer
Author: Yi-Xing Ren, Shuang Hao, Xi Jin, Fu-Gui Ye, Yue Gong, Yi-Zhou Jiang, Zhi-Ming Shao

Journal: BREAST, 2018, Vol.43, 97-104, DOI:10.1016/j.breast.2018.11.011
Ribociclib in hormone-receptor-positive advanced breast cancer: Establishing a value-based cost in China
Author: XiaoMin Wan, YuCong Zhang, JinAn Ma, Chongqing Tan, XiaoHui Zeng, LiuBao Peng

Journal: BREAST, 2018, Vol.43, 1-6, DOI:10.1016/j.breast.2018.10.004
Initial experience of automated breast volume scanning (ABVS) and ultrasound elastography in predicting breast cancer subtypes and staging
Author: Xiao-Lei Wang, Lin Tao, Xian-Li Zhou, Hong Wei, Jia-Wei Sun

Journal: BREAST, 2016, Vol.30, 130-135, DOI:10.1016/j.breast.2016.09.012
Predictive value of DCE-MRI for early evaluation of pathological complete response to neoadjuvant chemotherapy in resectable primary breast cancer: A single-center prospective study
Author: Ying-Shi Sun, Ying-Jian He, Jie Li, Yan-Ling Li, Xiao-Ting Li, Ai-Ping Lu, Zhao-Qing Fan, Kun Cao, Tao Ouyang

Journal: BREAST, 2016, Vol.30, 80-86, DOI:10.1016/j.breast.2016.08.017

Breast

胸部

期刊简介

投稿提示

中科院分区

JCR分区

CiteScore

期刊发文

相关期刊

怎样选择期刊

投稿相关问题

投稿后咨询